Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 18 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/15/2007


1.		Phase III Randomized Study of ARA-C/DNR vs DHAD/VP-16 Induction Therapy Followed by ARA-C/DNR Consolidation Therapy in Older Patients with Previously Untreated Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				56 and over				NCI				SWOG-9333 SWOG-9333

Last Modified: 8/1/1998 First Published: 8/1/1998


2.		Phase III Randomized Study of Pentoxifylline, Ciprofloxacin, and Dexamethasone Versus Amifostine in Patients with Myelodysplastic Syndromes (Summary Last Modified 08/1998)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				21 and over				Pharmaceutical / Industry				BOSTON-VAMC-523 ALZA-97-047-ii, NCI-V98-1422

Last Modified: 7/5/2007 First Published: 5/1/1999


3.		Phase III Randomized Study of Ciprofloxacin vs Cephalexin in Patients with Stage Ta Transitional Cell Carcinoma of the Bladder Treated with Transurethral Tumor Resection

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				SWOG-S9809 CLB-S9809, NCT00003824, S9809

Last Modified: 9/1/1999 First Published: 4/1/1998


4.		Phase I/II Study of Docetaxel/Cisplatin/Fluorouracil/Leucovorin Calcium in Patients with Advanced Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck (Summary Last Modified 09/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				DFCI-97130 NCI-G98-1385

Last Modified: 6/1/1994


5.		Phase I/II Study of BU/CTX plus Autologous or Syngeneic Bone Marrow Transplantation or Peripheral Blood Stem Cell Rescue in Patients with Advanced Multiple Myeloma (Summary Last Modified 06/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 to 65								FHCRC-336.3 NCI-V88-0470

Last Modified: 12/1/1994


6.		Phase II Study of Anti-TNF Therapy with PTX and CPFX in Patients Undergoing Ablative Chemoradiotherapy/Allogeneic Bone Marrow Transplantation for AML in First or Second Remission or First Relapse (Summary Last Modified 12/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				17 to 55								FHCRC-601.0 NCI-V94-0382

Last Modified: 5/10/2007


7.		Phase II Study of High-Dose CHOP (CTX/DOX/VCR/PRED) with G-CSF in Newly Diagnosed High-Risk non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 to 65				NCI				CLB-9351 CALGB-9351

Last Modified: 4/1/1998 First Published: 3/1/1998


8.		Phase II Study of Docetaxel/Cisplatin/Leucovorin Calcium/Fluorouracil in Patients with Locally Advanced Squamous cell Carcinoma of the Head and Neck (Summary Last Modified 04/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				any age				NCI				DFCI-96184 NCI-G98-1380

Last Modified: 6/1/1997


9.		Phase II Management of Fever and Infection in Cancer Patients --- Fever Study IV (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				any age				NCI				NCI-85-C-212C NCI-T86-0036N, T86-0036

Last Modified: 9/1/1993


10.		Phase II Study of High-Dose CEP (CTX/VP-16/CDDP) with GM-CSF and anti-TNF Therapy with Pentoxifylline/Ciprofloxacin as Consolidation in Patients with High-Risk Ovarian Cancer (Summary Last Modified 09/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				any age								PSOC-1204 NCI-V93-0244

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute